$0.03
arrow_drop_down49.31%Key Stats | |
---|---|
Open | $0.14 |
Prev. Close | $0.14 |
EPS | -0.05 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $28.31M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.05 | 0.14 |
52 Week Range | 0.05 | 0.54 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -0.05 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships
BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.
Global Alkyl Ketene Dimer Market Size To Worth USD 524.4 Million By 2033 | CAGR of 4.66% - GlobeNewswire
CEO UPDATE
How Communities Impact Penny Stocks, 3 Ways
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING